{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:06:27Z","timestamp":1791875187932,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,10]]},"DOI":"10.7759\/cureus.21085","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T18:48:31Z","timestamp":1641840511000},"source":"Crossref","is-referenced-by-count":6,"title":["A Rare Case of Epstein-Barr Virus: Infectious Mononucleosis Complicated by Guillain-Barr\u00e9 Syndrome"],"prefix":"10.7759","author":[{"given":"Oluseyi","family":"Abidoye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erine","family":"Raybon-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ogbuagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/132.5.546","article-title":"A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody","volume":"132","author":"Evans AS","year":"1975","unstructured":"Evans AS, Niederman JC, Cenabre LC, West B, Richards VA. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: specificity and sensitivity of the tests and persistence of antibody. J Infect Dis. 1975, 132:546-54. 10.1093\/infdis\/132.5.546","journal-title":"J Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-5876(01)00472-4","article-title":"Parotid mass: Epstein-Barr virus and facial paralysis","volume":"59","author":"Long CM","year":"2001","unstructured":"Long CM, Kerschner JE. Parotid mass: Epstein-Barr virus and facial paralysis. Int J Pediatr Otorhinolaryngol. 2001, 59:143-6. 10.1016\/s0165-5876(01)00472-4","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199905)45:5<659::aid-ana16>3.0.co;2-9","article-title":"Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host","volume":"45","author":"Schellinger PD","year":"1999","unstructured":"Schellinger PD, Sommer C, Leith\u00e4user F, Schwab S, Storch-Hagenlocher B, Hacke W, Kiessling M. Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host. Ann Neurol. 1999, 45:659-62. 10.1002\/1531-8249(199905)45:5&lt;659::aid-ana16&gt;3.0.co;2-9","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.5.1351","article-title":"Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF","volume":"48","author":"Tselis A","year":"1997","unstructured":"Tselis A, Duman R, Storch GA, Lisak RP. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology. 1997, 48:1351-5. 10.1212\/wnl.48.5.1351","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1001116","article-title":"Infectious mononucleosis","volume":"362","author":"Luzuriaga K","year":"2010","unstructured":"Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010, 362:1993-2000. 10.1056\/NEJMcp1001116","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","article-title":"Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus","volume":"85","author":"Anagnostopoulos I","year":"1995","unstructured":"Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995, 85:744-50. 10.1182\/blood.V85.3.744.bloodjournal853744","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5858\/1999-123-0875-IMIAOP","article-title":"Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients","volume":"123","author":"Brigden ML","year":"1999","unstructured":"Brigden ML, Au S, Thompson S, Brigden S, Doyle P, Tsaparas Y. Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients. Arch Pathol Lab Med. 1999, 123:875-81. 10.5858\/1999-123-0875-IMIAOP","journal-title":"Arch Pathol Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki N","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barr\u00e9 syndrome. N Engl J Med. 2012, 366:2294-304. 10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain-Barr\u00e9 syndrome","volume":"352","author":"Hahn AF","year":"1998","unstructured":"Hahn AF. Guillain-Barr\u00e9 syndrome. Lancet. 1998, 352:635-41. 10.1016\/S0140-6736(97)12308-X","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir074","article-title":"Guillain-Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study","volume":"52","author":"Orlikowski D","year":"2011","unstructured":"Orlikowski D, Porcher R, Sivadon-Tardy V, et al.. Guillain-Barr\u00e9 syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis. 2011, 52:837-44. 10.1093\/cid\/cir074","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(02)00418-5","article-title":"HIV-associated Guillain-Barr\u00e9 syndrome","volume":"208","author":"Brannagan TH 3rd","year":"2003","unstructured":"Brannagan TH 3rd, Zhou Y. HIV-associated Guillain-Barr\u00e9 syndrome. J Neurol Sci. 2003, 208:39-42. 10.1016\/s0022-510x(02)00418-5","journal-title":"J Neurol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire SK","year":"2018","unstructured":"Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018, 102:84-92. 10.1016\/j.jcv.2018.03.001","journal-title":"J Clin Virol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs BC","year":"1998","unstructured":"Jacobs BC, Rothbarth PH, van der Mech\u00e9 FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA. The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study. Neurology. 1998, 51:1110-5. 10.1212\/wnl.51.4.1110","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(72)92654-2","article-title":"Epstein-Barr virus and Guillain-Barr\u00e9 syndrome","volume":"2","author":"Grose C","year":"1972","unstructured":"Grose C, Feorino PM. Epstein-Barr virus and Guillain-Barr\u00e9 syndrome. Lancet. 1972, 2:1285-7. 10.1016\/s0140-6736(72)92654-2","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke C","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014, 137:33-43. 10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison HJ","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome. Lancet. 2016, 388:717-27. 10.1016\/S0140-6736(16)00339-1","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden RD","year":"1998","unstructured":"Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV. Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Ann Neurol. 1998, 44:780-8. 10.1002\/ana.410440512","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome","volume":"62","author":"Hughes RA","year":"2005","unstructured":"Hughes RA, Wijdicks EF, Benson E, et al.. Supportive care for patients with Guillain-Barr\u00e9 syndrome. Arch Neurol. 2005, 62:1194-8. 10.1001\/archneur.62.8.1194","journal-title":"Arch Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31824de293","article-title":"Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"78","author":"Patwa HS","year":"2012","unstructured":"Patwa HS, Chaudhry V, Katzberg H, Rae-Grant AD, So YT. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2012, 78:1009-15. 10.1212\/WNL.0b013e31824de293","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barre syndrome","volume":"80","author":"van den Berg B","year":"2013","unstructured":"van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013, 80:1650-4. 10.1212\/WNL.0b013e3182904fcc","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80639-a-rare-case-of-epstein-barr-virus-infectious-mononucleosis-complicated-by-guillain-barr-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:38Z","timestamp":1707507758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80639-a-rare-case-of-epstein-barr-virus-infectious-mononucleosis-complicated-by-guillain-barr-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.21085","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}